INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
Drug Delivery & Environmental Sustainability
139
Issue No #139 Oct Nov 2022
November 8th, 2022
Download PDF
Issue 139 - OctNov 2022
Inside the magazine
EXPERT VIEW
Cormac O'Prey
SUSTAINABLE DESIGN & MANUFACTURE IN MEDICAL DEVICES: WHERE TO START
Cormac O’Prey discusses the challenges and advantages of implementing circular economy principles in the medical device sector, with a particular consideration of the difficulty of making remanufacturing work for high-volume, low-value devices.
SUSTAINABILITY
Dr Peter Hirst
Recipharm
WHY PARTNERSHIPS ARE KEY TO A MORE SUSTAINABLE PHARMA INDUSTRY
Peter Hirst argues that careful selection of partners and better collaboration throughout the supply chain are key to optimising the sustainability of the pharmaceutical industry.
SUSTAINABILITY
Phil Seeney
PA Consulting
MAKING SUSTAINABILITY BY DESIGN THE LINTEL OF SUSTAINABLE INHALER DEVELOPMENT
Phil Seeney, Philip Winkworth and Craig Nelson provide an insight into sustainability developments in the pharmaceutical industry, with a focus on inhalables.
SUSTAINABILITY
Dr Iain Simpson
Phillips Medisize
CONSIDERING THE SUSTAINABILITY IMPACT OF CONNECTED INHALERS IN THE TREATMENT OF ASTHMA
Iain Simpson and Vinith Bhandari consider the sustainability impact of device connectivity specific to asthma inhalers through the reduction of greenhouse gas emissions.
SUSTAINABILITY
Matthias Birkhoff
Aptar Pharma
SUSTAINABILITY MEASURES ARE THE KEY TO MEETING ESG COMMITMENTS
Matthias Birkhoff and Christophe Marie discuss the advances Aptar Pharma has made in delivering on its sustainability objectives.
SUSTAINABILITY
Sebastian Gerner
Ypsomed
YPSOMED’S TWO-STEP APPROACH TO ACHIEVING NET ZERO
Sebastien Gerner discusses Ypsomed’s approach to achieving its net zero objectives, both looking back at Step One of the company’s approach and outlining the upcoming Step Two.
EXPERT VIEW
Alastair Willoughby
THE ENVIRONMENTAL IMPACT OF GLOBAL SUPPLY CHAIN LOGISTICS & SUPPLIER SELECTION
Alastair Willoughby looks at the factors affecting sustainability when considering global supply chain logistics and supplier selection.
EXPERT VIEW
Catriona Eldridge
CLIMATE CHANGE AND THE PHARMACEUTICAL INDUSTRY: TOO LITTLE, TOO LATE?
Catriona Eldridge and Omar Shah discuss the findings of a recent investigative assessment into the environmental impact of healthcare products, and consider whether or not the pharmaceutical industry is doing enough to combat climate change.
SUSTAINABILITY
Stefano Vicenzetto
Flex
SUSTAINABLE DESIGN FOR MEDICAL DEVICES
How do you meet environmental and sustainability objectives when designing medical devices? And what design considerations enable the technical cycles, known as the 4R loops of circular economy: reuse, repair, remanufacture and recycle? Stefano Vicenzetto explores the Flex approach to design for environment for medical devices.
Top